埃托波西德和西斯普拉丁与anlotinib结合治疗NUT肺癌:一个病例报告
Yuxing Sun1, Jiangyu Bian1, Linfeng Wang2
1Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in oncology
|October 3, 2025
概括
这项研究详细介绍了一个罕见的侵袭性肺NUT癌症病例. 手术,化疗和向治疗的结合导致了超过4个月的无进展生存,提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 肺NUT癌是一种具有攻击性,罕见的恶性瘤,预后不佳.
- 早期诊断具有挑战性,治疗选择有限.
研究的目的:
- 报告一种罕见的原发性肺NUT癌症病例的治疗和结果.
- 为这种具有挑战性的疾病提供一个可行的治疗选择.
主要方法:
- 瘤的手术切除.
- 辅助化疗 辅助化疗.
- 针对性治疗的管理.
主要成果:
- 患者在治疗后实现了超过4个月的无进展生存期.
- 这一结果表明多模式治疗方法的潜在好处.
结论:
- 包括手术,化疗和向治疗在内的多模式治疗可能为肺部NUT癌症提供一个可行的选择.
- 需要进一步的研究,以建立这种罕见的癌症的有效治疗方案.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K